FNY Investment Advisers’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,310
Closed -$6K 983
2025
Q4
$6K Sell
1,310
-902
-41% -$4.02K ﹤0.01% 713
2025
Q3
$10K Buy
2,212
+1,322
+149% +$5.21K ﹤0.01% 797
2025
Q2
$2K Buy
890
+110
+14% +$271 ﹤0.01% 846
2025
Q1
$2K Buy
+780
New +$2.52K ﹤0.01% 643
2024
Q2
Sell
-1,384
Closed -$13 655
2024
Q1
$13 Sell
1,384
-8
-0.6% -$70 0.01% 420
2023
Q4
$9K Buy
+1,392
New +$9.26K 0.01% 321
2023
Q2
Sell
-900
Closed -$5K 630
2023
Q1
$5K Buy
+900
New +$5.96K 0.01% 395
2022
Q3
Sell
-123
Closed -$1K 758
2022
Q2
$1K Buy
+123
New +$1.83K ﹤0.01% 631
2022
Q1
Sell
-300
Closed -$7K 844
2021
Q4
$7K Buy
+300
New +$8.29K ﹤0.01% 414

Other funds holding MSOS

FNY Investment Advisers's MSOS Position: Q2 2026 in Review

FNY Investment Advisers reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 66% in Q2 2026, selling an estimated $323K and leaving 35,409 shares worth $179K. The position accounts for 0.06% of the portfolio, ranked #250.

FNY Investment Advisers first reported a position in MSOS in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.48M in Q4 2023. 55 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • FNY Investment Advisers held 35,409 shares of AdvisorShares Pure US Cannabis ETF worth $179K as of Q2 2026.
  • FNY Investment Advisers sold 68,953 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $323K.
  • AdvisorShares Pure US Cannabis ETF made up 0.06% of FNY Investment Advisers's portfolio in Q2 2026, its #250 holding.
  • FNY Investment Advisers first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and has held it in 18 quarters since.
  • FNY Investment Advisers's AdvisorShares Pure US Cannabis ETF position peaked at $2.48M in Q4 2023.
  • 55 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.